Sbir 133 - antigen
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93024C00044
- Awardee
-
Immport Therapeutics Inc. UEI ZJAMPJY7M149
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Irvine, CA 92618, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $300,000 |
About this award
This is a $300,000.00 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract is for SBIR 133 - ANTIGEN and has an ultimate completion date of September 9, 2025. Immport Therapeutics is a biotechnology company that specializes in protein microarray technology and related services to support infectious disease detection, monitoring, and research. The company has previously provided products and services to support federal efforts related to pathogens such as monkeypox, SARS-CoV-2, and Cryptosporidium under other federal contract and grant awards. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N93024C00044?
75N93024C00044 was awarded to Immport Therapeutics Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 10, 2024.
How much is contract 75N93024C00044 worth?
The government has obligated $300,000 on 75N93024C00044.
Was contract 75N93024C00044 competed?
The extent of competition for 75N93024C00044 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award